Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hagan

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
The Journal of Biological Chemistry|October 12, 2024
Site-specific O-GlcNAcylation of progesterone receptor (PR) supports PR attenuation of interferon stimulated genes (ISGs) and tumor growth in breast cancerHarmony I Saunders, Sean M Holloran, Gloria M Trinca, et al.
Scientific Reports|November 18, 2022
Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell lineCraig M Rush, Zannel Blanchard, Jacob T Polaski, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 12, 2015
X-ray, spectroscopic and normal-mode dynamics of calexcitin: structure-function studies of a neuronal calcium-signalling proteinP T Erskine, A Fokas, C Muriithi, et al.
Psychological Bulletin|October 27, 2017
The interpersonal theory of suicide: A systematic review and meta-analysis of a decade of cross-national researchCarol Chu, Jennifer M Buchman-Schmitt, Ian H Stanley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2019
Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast CancerMerit L Goodman, Gloria M Trinca, Katherine R Walter, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 18, 2019
Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot StudyCarol J Fabian, Lauren Nye, Kandy R Powers, et al.
Cancer Research|May 19, 2017
NEMO, a Transcriptional Target of Estrogen and Progesterone, Is Linked to Tumor Suppressor PML in Breast CancerHanan S Elsarraj, Kelli E Valdez, Yan Hong, et al.
Scientific Reports|January 4, 2017
Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitorM Flinspach, Q Xu, A D Piekarz, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 16, 2023
Global expression analysis of endometrial cancer cells in response to progesterone identifies new therapeutic targetsKristina W Thiel, Andreea M Newtson, Eric J Devor, et al.
Journal for Immunotherapy of Cancer|March 18, 2025
Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancerJulio C Tinoco, Harmony I Saunders, Lauryn Rose Werner, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|October 12, 2024
Site-specific O-GlcNAcylation of progesterone receptor (PR) supports PR attenuation of interferon stimulated genes (ISGs) and tumor growth in breast cancerHarmony I Saunders, Sean M Holloran, Gloria M Trinca, et al.
Scientific Reports|November 18, 2022
Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell lineCraig M Rush, Zannel Blanchard, Jacob T Polaski, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 12, 2015
X-ray, spectroscopic and normal-mode dynamics of calexcitin: structure-function studies of a neuronal calcium-signalling proteinP T Erskine, A Fokas, C Muriithi, et al.
Psychological Bulletin|October 27, 2017
The interpersonal theory of suicide: A systematic review and meta-analysis of a decade of cross-national researchCarol Chu, Jennifer M Buchman-Schmitt, Ian H Stanley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2019
Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast CancerMerit L Goodman, Gloria M Trinca, Katherine R Walter, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 18, 2019
Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot StudyCarol J Fabian, Lauren Nye, Kandy R Powers, et al.
Cancer Research|May 19, 2017
NEMO, a Transcriptional Target of Estrogen and Progesterone, Is Linked to Tumor Suppressor PML in Breast CancerHanan S Elsarraj, Kelli E Valdez, Yan Hong, et al.
Scientific Reports|January 4, 2017
Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitorM Flinspach, Q Xu, A D Piekarz, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 16, 2023
Global expression analysis of endometrial cancer cells in response to progesterone identifies new therapeutic targetsKristina W Thiel, Andreea M Newtson, Eric J Devor, et al.
Journal for Immunotherapy of Cancer|March 18, 2025
Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancerJulio C Tinoco, Harmony I Saunders, Lauryn Rose Werner, et al.
Pageof 12